151 related articles for article (PubMed ID: 37484857)
1. Trends in innovative pediatric drug development in China based on clinical trial registration data.
Wu WW; Ji X; Mou XS; Ma XY; Huang YT; Zhang JY; Zhang JX; Xie XR; Mao NY; Xu J
Front Med (Lausanne); 2023; 10():1187547. PubMed ID: 37484857
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Clinical Trials in Mainland China Over the Past Decade (From 2009 to 2020).
Wu WW; Ji X; Wang H; Chen F; Ding Q; Zhang GD; Li M; Wang SS; Ni MM; Liu QQ; Xu J; Wang Q
Front Med (Lausanne); 2021; 8():745676. PubMed ID: 34671625
[TBL] [Abstract][Full Text] [Related]
3. Review of the Chinese Landscape in Phase 1 Clinical Trials for Noncancer Innovative Drugs Over 2015 to 2020.
Wu X; Zhang F; Yu M; Wang H
Clin Pharmacol Drug Dev; 2022 Aug; 11(8):903-909. PubMed ID: 35711154
[TBL] [Abstract][Full Text] [Related]
4. Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review.
Li N; Huang HY; Wu DW; Yang ZM; Wang J; Wang JS; Wang SH; Fang H; Yu Y; Bai Y; Yan Z; Cao Y; Jiang M; Liu YF; Li KY; Xu BH; Sun Y; He J
Lancet Oncol; 2019 Nov; 20(11):e619-e626. PubMed ID: 31674320
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010-2019.
Liu X; Wu S; Sun J; Ni S; Lu L; Hu W; Wei H; Zou Y; Li T; Li J; Mijiti B; Fang P; Zhao L; Zhou H; Xing X; Niu H; Cao Y
Pharmacol Res Perspect; 2021 Apr; 9(2):e00729. PubMed ID: 33660404
[TBL] [Abstract][Full Text] [Related]
7. Recent landscape and trends for industry-sponsored pediatric clinical trials in China from 2013 to 2022.
Liu C; Liu Y; Ou L; Qi Y; Zhang J
Pediatr Investig; 2024 Mar; 8(1):12-20. PubMed ID: 38516137
[TBL] [Abstract][Full Text] [Related]
8. Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021.
Bo C; Wang T; Hou C; Han J; Chen L; Zhang H; Wang L; Li H
CNS Neurosci Ther; 2022 Aug; 28(8):1229-1239. PubMed ID: 35642775
[TBL] [Abstract][Full Text] [Related]
9. Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011-2020).
Chen C; Lou N; Zheng X; Wang S; Chen H; Han X
Front Med (Lausanne); 2021; 8():777698. PubMed ID: 34977078
[No Abstract] [Full Text] [Related]
10. Analysis of clinical trials of new drugs in China as of 2019.
Lin L; Chen Y; Yan L; Liu Y; Ni J; Yang H; Li H
Drug Discov Today; 2020 Dec; 25(12):2080-2088. PubMed ID: 33017690
[TBL] [Abstract][Full Text] [Related]
11. Current situation of pediatric clinical trials in China: focus on trials for drug marketing application and administrative approval.
Song L; Jia Y; Ran S; Li B; Xu J; Huo B; Yin N; Ai M; Liu Y
BMC Pediatr; 2022 Mar; 22(1):144. PubMed ID: 35303815
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
Shi YZ; Hu H; Wang C
Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021.
Hao J; Li C; Li J; Wang C; Li Y; He C; Liu W; Li S; Zuo L; Hui W
Am J Cardiovasc Drugs; 2023 May; 23(3):301-310. PubMed ID: 36917444
[TBL] [Abstract][Full Text] [Related]
15. Research and development of mAb drugs in China: a look from policy perspectives.
Jiang R; Sun Y; Ung C; Dong X; Kong X; Hu Y; Shao R
Hum Vaccin Immunother; 2019; 15(11):2695-2705. PubMed ID: 31116629
[No Abstract] [Full Text] [Related]
16. [Progress on clinical trials of common gastrointestinal cancer drugs in China from 2012 to 2021].
Huang HY; Wu DW; Zhu Q; Yu Y; Wang HX; Wang J; Ga M; Meng XY; Du JT; Miao SM; Zhao ZX; Wang X; Shang P; Guo MJ; Liu LH; Tang Y; Li N; Cao C; Xu BH; Sun Y; He J
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):276-281. PubMed ID: 35316878
[No Abstract] [Full Text] [Related]
17. Current clinical trials on breast cancer in China: A systematic literature review.
Fan Y; Xu B
Cancer; 2020 Aug; 126 Suppl 16():3811-3818. PubMed ID: 32710659
[TBL] [Abstract][Full Text] [Related]
18. [Progress on clinical trials of cancer drugs in China, 2020].
Wu DW; Huang HY; Tang Y; Wang HX; Wang J; Wang SH; Fang H; Yang XY; Li J; Wang X; Liu LJ; Yan Y; Wang Q; Li N; Cao C; Xu BH; Sun Y; He J
Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):218-223. PubMed ID: 33601488
[No Abstract] [Full Text] [Related]
19. [Thoughts on path of R&D and registration of innovative traditional Chinese medicine with synchronous transformation of "series prescriptions"].
Ai YL; Tang JY; Zhou G; Zhang L; Qu LP; Huang SY; Yang ZQ; Yuan WA; Zhou YH; Wang T; Zhao JN; Sun XB; Xiao XH; Yang ZF; Liu QQ; Zhu MJ; Leng XY; Xie CG; Chai SY
Zhongguo Zhong Yao Za Zhi; 2022 Feb; 47(4):1120-1125. PubMed ID: 35285213
[TBL] [Abstract][Full Text] [Related]
20. Biologics for Non-Cancer Dermatological Diseases: Analysis on China's Clinical Trial Registration Trend From 2016 to 2020.
Zhu B; Liu Y; Li J; Ni Q; Yin Z; Zhu J; Chen K; Yang X
Front Pharmacol; 2022; 13():817065. PubMed ID: 35529441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
